Global Duodenoscopes Market Size, Share, and COVID-19 Impact By Product Type (Reusable Duodenoscopes and Single-Use Duodenoscopes), By Application (Diagnostics and Therapeutics), By End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Duodenoscopes Market Insights Forecasts to 2033

• The Global Duodenoscopes Market Size was Estimated at USD 1.53 Billion in 2023
• The Market Size is Expected to Grow at a CAGR of around 5.49% from 2023 to 2033
• The Worldwide Duodenoscopes Market Size is Expected to Reach USD 2.61 Billion by 2033
• Europe is Expected to Grow the fastest during the forecast period.

The global duodenoscopes market was size worth around USD 1.53 Billion in 2023 and is predicted to grow to around USD 2.61 Billion by 2033 with a compound annual growth rate (CAGR) of 5.49% between 2023 and 2033. The market is driven by the growing number of gastrointestinal illnesses, technological developments related to endoscope equipment, the growing adoption of ERCP procedure, massive expenditures on research and development, as well as enabling regulatory policies.

Market Overview

The duodenoscopes market refers to specialized endoscopic devices for duodenum and duct procedures. With a light, camera, and tool channel, they enable doctors to visually examine internal structures and conduct treatments. Primarily utilized during ERCP, duodenoscopes help diagnose and treat digestive diseases, clear obstructions, and obtain tissue samples from the bile and pancreatic ducts. The duodenoscopes market offers a high degree of opportunities for growth due to technological advances, rising prevalence of gastrointestinal disorders, and the growing demand for minimally invasive treatments. Furthermore, the convergence of high-definition imaging systems, enhanced manoeuvrability, and new therapeutic functions in duodenoscopes will likely accelerate their uptake across a range of healthcare facilities. Moreover, increasing attention to patient safety and infection prevention is propelling demand for single-use duodenoscopes, opening up new opportunities for market growth. In addition, the technological advancements, especially in the areas of imaging and safety, have spurred the introduction of new models. For example, Olympus introduced the TJF-Q190V duodenoscope in June 2020, which got FDA clearance in January 2020 because of its cutting-edge design featuring a sterile, single-use distal endcap aimed at enhancing reprocessing and minimizing contamination risks. This new model hopes to enable more secure ERCP procedures by offering physicians state-of-the-art instruments while upholding rigorous patient safety guidelines.

Report Coverage

This research report categorizes the duodenoscopes market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the duodenoscopes market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the duodenoscopes market.

Driving Factors

The duodenoscopes market is driven by some major trends. The main impetus for market growth comes from the growing incidence of gastrointestinal disorders, specifically pancreas- and bile duct-related cancers. Growing numbers of diagnoses for pancreatic cancer, bile duct cancer, and other diseases of the gastrointestinal tract require more sophisticated diagnostic instruments like duodenoscopes. Additionally, ongoing innovations in imaging technology enhance diagnostic accuracy and procedural success. The availability of flexible video duodenoscopes has greatly enhanced procedural visualization, and these are more effective than the earlier non-video types. Moreover, innovations like single-use duodenoscopes are being developed to mitigate infection control concerns with reusable devices. Furthermore, technological innovations are increasingly improving the capabilities of both reusable and disposable duodenoscopes. Manufacturers are putting research and development dollars into making these instruments more image-intensive, flexible, and easier to navigate, which improves diagnostic and therapeutic yields.

Restraining Factors

The duodenoscopes market encounters certain difficulties that would restrain its development. The main hurdles are the prohibitively expensive cost involved in newer model duodenoscope models, most notably single-use devices, to restricts their popularity in price-conscious markets and financially-strapped health facilities. Additionally, infection control and reprocessing issues of reusable duodenoscopes continue to be an important constraint, and there needs to be ongoing developments in device design and reprocessing procedures to provide patient safety and uphold market confidence.

Market Segmentation

The duodenoscopes market share is classified into product type, application, and form.

• The reusable duodenoscopes segment held the largest share of the market in 2023 and is projected to grow at a substantial CAGR during the forecast period.

Based on product type, the duodenoscopes market is segmented into reusable duodenoscopes and single-use duodenoscopes. Among these, the reusable duodenoscopes segment held the largest share of the market in 2023 and is projected to grow at a substantial CAGR during the forecast period. The segmental growth is due to their cost savings and high usage in healthcare facilities and hospitals. Additionally, they are meant to be used many times, with them being cleaned properly and sterilized between uses, which, as much as they are cost-saving, causes concerns regarding possible infection risks caused by possible negligence in reprocessing procedures.

• The therapeutics segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on application, the duodenoscopes market is segmented into diagnostics and therapeutics. Among these, the therapeutics segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The growth is driven by the rising incidence of gastrointestinal disorders, improvements in medical technology, and the trend toward minimally invasive surgery. Additionally, increasing rates of gastrointestinal disease like pancreatic cancer, bile duct obstruction, and chronic pancreatitis, demand for useful diagnostic and therapeutic instruments like duodenoscopes has skyrocketed.

• The hospitals segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on end-user, the global duodenoscopes market is categorized into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospitals segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment's growth is attributed to their large-scale infrastructure, access to trained healthcare experts, and increased patient volume. In addition, the use of advanced technologies and strict regulatory compliance in hospital environments increases the procedural success rates, thus contributing to the large market share of this segment.

Regional Segment Analysis of the Duodenoscopes Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the duodenoscopes market over the predicted timeframe.

North America is anticipated to hold the largest share of the duodenoscopes market over the predicted period. The dominance is due to the growing healthcare infrastructure. North America's healthcare infrastructure is well developed, with huge investments in medical technology and high levels of healthcare spending allowing for the use of advanced medical devices like duodenoscopes. Furthermore, growing preference among patients and healthcare professionals for minimally invasive procedures also adds to the growing demand for duodenoscopes.

Europe is expected to grow rapidly in the duodenoscope market during the forecast period. The market in the region is driven by increasing geriatric population, advances in medical research and development, and the availability of major medical device manufacturers. Moreover, in Europe, duodenoscope demand is fueled by the increasing rate of pancreatic and biliary ailments and the rise in focus on minimally invasive procedures.

Competitive Analysis:

The report offers an appropriate analysis of the key organization markets/companies involved within the duodenoscopes market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, business strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Olympus Corporation
• Fujifilm Holdings Corporation
• Pentax Medical (Hoya Corporation)
• Karl Storz SE & Co. KG
• Boston Scientific Corporation
• Cook Medical
• Ambu A/S
• Conmed Corporation
• Medtronic plc
• Ethicon Endo-Surgery, Inc. (Johnson & Johnson)
• Richard Wolf GmbH
• Stryker Corporation
• Smith & Nephew plc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In April 2024, Ambu announces U.S. Food and Drug Administration (FDA) 510(k) regulatory clearance for its next-generation duodenoscopy solution, Ambu aScope Duodeno 2 and Ambu aBox 2, for ERCP1 procedures.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the duodenoscopes market based on the below-mentioned: 

Global Duodenoscopes Market, By Product Type

• Reusable Duodenoscopes
• Single-Use Duodenoscopes

Global Duodenoscopes Market, By Application

• Diagnostics
• Therapeutics

Global Duodenoscopes Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty

Global Duodenoscopes Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa